WHO has prequalified the cobas® MTB‑RIF/INH assay, confirming its compliance with international quality, safety, and performance requirements under the WHO Prequalification programme for IVDs. The assay supports WHO‑recommended molecular testing for tuberculosis and detection of resistance to rifampicin and isoniazid. This listing contributes to improved access to quality‑assured diagnostics in high‑burden and resource‑limited settings.